medicine |ˈmedisən|
noun
1 the science or practice of the diagnosis, treatment, and prevention of disease (in technical use often taken to exclude surgery).
2 a compound or preparation used for the treatment or prevention of disease, esp. a drug or drugs taken by mouth : give her some medicine | your doctor will be able to prescribe medicines.
• such substances collectively : an aid convoy loaded with food and medicine.
3 (among North American Indians and some other peoples) a spell, charm, or fetish believed to have healing, protective, or other power : Fleur was murdering him by use of bad medicine.
Below is the appendix from Robert Whitaker's "The Case Against Antipsychotic Drugs: A 50 Year Record Of Doing More Harm Than Good." The full, free Whitaker pdf, and more, is Here
read the timeline/negative effects and compare them to definitions:
1: prevention of disease
2: prevention of disease
3: healing, protective or other power
1883: Phenothiazines developed as synthetic dyes.
1934: USDA develops phenothiazines as insecticide.
1948: Phenothiazines shown to hinder rope-climbing abilities in rats.
1950: Rhone Poulenc synthesizes chlorpromazine.
Clinical History Standard Neuroleptics
1954: Chlorpromazine, marketed in the United States as Thorazine, found to induce symptoms of Parkinson's disease.
1955: Chlorpromazine said to induce symptoms similar to encephalitis lethargica.
1959: First reports of permanent motor dysfunction linked to neuroleptics, later named tardive dyskinesia.
1960: French Physicians describe a potentially fatal toxic reaction to neuroleptics, later named neuroleptic malignant syndrome.
1962: California Mental Hygiene Department determines that chlorpromazine and other neuroleptics prolong hospitalization.
1963: Six-week NIMH collaborative study concludes that neuroleptics are safe and effective "antischizophrenic" drugs.
1964: Neuroleptics found to impair learning in animals and humans.
1965: One-year followup of NIMH collaborative study finds drug treated patients more likely than placebo patients to be rehospitalized.
1968: In a drug withdrawal study, the NIMH finds that relapse rates rise in direct relation to dosage.
1972: Tardive diskinesia is said to resemble Huntington's Disease, is said to resemble "postencephalitic brain damage".
1974: Boston researchers report that relapse rates were lower in pre-neuroleptic era, and that drug treated patients, were more likely to be socially dependent.
1977: A NIMH study that randomizes Schizophrenia patients into drug and non-drug arms reports that only 35% of the non-medicated patients relapsed within a year after discharge, compared to 45% of those treated with medication.
1978: California investigator Maurice Rappaport reports markedly superior three-year outcomes for patients treated without neuroleptics. Only 27% of the drug free patients relapsed in the three years following discharge, compared to 62% of the medicated patients.
1978: Canadian researchers describe drug induced changes in the brain that make a patient more vulnerable to relapse, which they dub "neuroleptic induced supersensitive psychosis."
1978: Neuroleptics found to cause 10% cellular loss in brains of rats.
1979: Prevalence of Tardive Diskinesia in drug treated patients is reported to range from 24% to 56%.
1979: Tardive Diskinesia found to be associated with cognitive impairment.
1979: Loren Mosher: chief of schizophrenia studies at the NIMH, reports superior one-year and two-year outcomes for Soteria patients treated without neuroleptics.
1980: NIMH researchers find an increase in "blunted effect" and "emotional withdrawal" in drug treated patients who don't relapse, and that neuroleptics do not improve "social and role performance" in non-relapsers.
1982: Anticholinergic medications used to treat Parkinsonian symptoms induced by neuroleptics reported to cause cognitive impairment.
1985: Drug induced Akathisia is linked to suicide.
1985: Case reports link drug induced Akathisia to violent homicides.
1987: Tardive diskinesia is linked to worsening of negative symptoms, gait difficulties, speech impairment, psychsocial deterioration, and memory deficits. They conclude it may be both a "motor and dementing" disorder.
1992: World Health Organization reports that Schizophrenia outcomes are much superior in poor countries, where only 16% of patients are kept continuously on neuroleptics. The WHO concludes that living in a developed nation is a "strong predictor" that a patient will never fully recover.
1992: Researchers acknowledge that neuroleptics cause a recognizable pathology, which they name neuroleptic induced deficit syndrome. In addition to Parkinson's, akathisia, blunted emotions and tardive dyskinesia, patients treated with neuroleptics suffer from an increased incidence of blindness, fatal blood clots, arrythmia, heat stroke, swollen breasts, leaking breasts, impotence, obesity, sexual dysfunction, blood disorders, skin rashes, seizures, and early death.
1994: Neuroleptics found to cause an increase in the volume of the caudate region in the brain.
1994 Harvard investigators report that schizophrenia outcomes in the US appear to have worsened over past 20 years, and are now no better than in first decades of 20th century.
1995 “Real world” relapse rates for schizophrenia patients treated with neuroleptics said to be above 80% in the two years following hospital discharge, which is much higher than in pre-neuroleptic era.
1995 “Quality of life” in drug-treated patients reported to be “very poor”.
1998 MRI studies show that neuroleptics cause hypertrophy of the caudate, putamen and thalamus, with the increase “associated with greater severity of both negative and positive symptoms”.
1998 Neuroleptic use is found to be associated with atrophy of cerebral cortex.
1998 Harvard researchers conclude that “oxidative stress” may be the process by which neuroleptics cause neuronal damage in the brain.
1998 Treatment with two or more neuroleptics is found to increase risk of early death.
2000 Neuroleptics linked to fatal blood clots.
2003 Atypicals linked to an increased risk of obesity, hyperglycemia, diabetes, and pancreatitis.
And Here: Mr Whitaker provides more:
2005 NIMH Researchers report that atypical antipsychotics provide few, if any, benefits compared to the old neuroleptics
2006 Suicide rates for schizophrenic patients is reported to be 20 times higher today than it was a century ago.
2007 British researchers report that quality of life was better on old drugs than on atypicals.
2007 Illinois investigators report that long-term recovery rates for unmedicated schizophrenia patients are eight times higher than for medicated patients.
Children are being crippled with these toxins for being inattentive and fidgeting at school. The elderly in Nursing homes are being Killed with these toxins for being 'uppity'.
Now, ..... go to Dr. Bonker's Historic Mental Medicine Show, and have a good look around.
The Collier's Graphic is from 1906. Click it, expand it, and read it.
Psychiatry, It's A Killing: In Exchange for Drug Money.
"Twas Ever Thus." Mr. Natural
